608137-33-3 Lisdexamfetamine dimesylate 99%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:1MT
- Time:2024-02-24
Product Details
- Product NameLisdexamfetamine dimesylate
- CAS No.608137-33-3
- EINECS No.200-659-6
- MFC16H29N3O4S
- MW359.49
- AppearanceA neat solid
- storage temp. -20°C
Company Profile Introduction
Headquartered in Chandigarh, India, Ind-Swift Laboratories Ltd. today is a global manufacturer of APIs, Intermediates, and formulations (through group collaboration). With regulated 6+ manufacturing sites (including 2 group subsidiaries) in Punjab and Jammu, we cater to the API needs of regulated markets including USFDA, EDQM, PMDA, ANVISA, EU-GMP, KFDA, NMO, ANSM, Cofepris, TGA, WHO, ROW.
Today, Ind-Swift Laboratories Ltd. is a significant player in manufacturing APIs towards Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Antimigraine, Parkinson’s Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence and Bone Resorption Inhibitor. We also hold global leadership positions in the Macrolide Antibiotic segment
Our organization’s manufacturing facilities are enabled with state-of-art infrastructure, that enables us to comply with our global aspirations. On grounds of consistent regulatory approvals, our products are today being supplied across the globe.
Today, Ind-Swift Laboratories Ltd. is a significant player in manufacturing APIs towards Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Antimigraine, Parkinson’s Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence and Bone Resorption Inhibitor. We also hold global leadership positions in the Macrolide Antibiotic segment
Our organization’s manufacturing facilities are enabled with state-of-art infrastructure, that enables us to comply with our global aspirations. On grounds of consistent regulatory approvals, our products are today being supplied across the globe.
Supplier other products
Recommended supplier
-
VIP1年
- Zenfold Sustainable Technologies (ZST)
- 608137-32-2 98%
- Inquiry
- 2024-01-18
-
VIP1年
- Embio Limited
- Lisdexamfetamine 99%
- Inquiry
- 2023-12-30
- Since:2020-02-01
- Address: 711-712, Modi Tower, 98 Nehru Place, New Delhi-160101, India.
INQUIRY